These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 8217299)
1. [Study on plasma levels of vasoactive intestinal peptide (VIP) in patients with allergic rhinitis]. Zhang RX Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(3):165-6, 187-8. PubMed ID: 8217299 [TBL] [Abstract][Full Text] [Related]
2. [Substance P in plasma of patients with allergic rhinitis and its clinical significance]. Zhang RX Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(2):72-3, 123. PubMed ID: 7692902 [TBL] [Abstract][Full Text] [Related]
3. Alterations of vasoactive intestinal polypeptide receptors in allergic rhinitis. Kim DH; Park IH; Cho JS; Lee YM; Choi H; Lee HM Am J Rhinol Allergy; 2011; 25(1):e44-7. PubMed ID: 21711977 [TBL] [Abstract][Full Text] [Related]
4. [Laser Doppler flowmetry for evaluation of nasal mucosa microcirculation]. Liu D; Zhao Y; Zhou Y Zhonghua Er Bi Yan Hou Ke Za Zhi; 1994; 29(6):366-7. PubMed ID: 7742031 [TBL] [Abstract][Full Text] [Related]
5. Substance P and vasoactive intestinal peptide in nasal secretions and plasma from patients with nasal allergy. Chaen T; Watanabe N; Mogi G; Mori K; Takeyama M Ann Otol Rhinol Laryngol; 1993 Jan; 102(1 Pt 1):16-21. PubMed ID: 7678375 [TBL] [Abstract][Full Text] [Related]
6. Expression of substance P, vasoactive intestinal peptide and heat shock protein 70 in nasal mucosal smears of patients with allergic rhinitis: investigation using a liquid-based method. Chalastras T; Nicolopoulou-Stamati P; Patsouris E; Eleftheriadou A; Kandiloros D; Yiotakis I; Gonidi M; Athanassiadou P J Laryngol Otol; 2008 Jul; 122(7):700-6. PubMed ID: 18282334 [TBL] [Abstract][Full Text] [Related]
7. Experimental studies for botulinum toxin type A on allergic rhinitis in the rat. Wen WD; Yuan F; Hou YP; Song YF Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Feb; 39(2):97-101. PubMed ID: 15195592 [TBL] [Abstract][Full Text] [Related]
8. [Effects of electroacupuncture on plasma vasoactive intestinal peptide and substance P in perennial allergic rhinitis patients]. Li YM; Zhuang LX; Lai XS; Jiang GH Zhen Ci Yan Jiu; 2007 Apr; 32(2):136-8. PubMed ID: 17650661 [TBL] [Abstract][Full Text] [Related]
9. [Microcirculation in nasal mucosa of healthy subjects and patients with rhinitis and maxillary sinusitis]. Aniutin RG; Ivkina SV Vestn Otorinolaringol; 2009; (3):8-10. PubMed ID: 19692955 [TBL] [Abstract][Full Text] [Related]
10. [The investigation for the neuropeptides of nasal septum in perennial allergic rhinitis patient]. Zhu Q; Zhang S; Wu J; Tang H Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Apr; 23(8):339-42. PubMed ID: 19685709 [TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal peptide in cirrhotic rats: hemodynamic effects and mesenteric arterial receptor characteristics. Lee SS; Huang M; Ma Z; Rorstad O Hepatology; 1996 May; 23(5):1174-80. PubMed ID: 8621151 [TBL] [Abstract][Full Text] [Related]
12. Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients. Bellamy JL; Cady RK; Durham PL Headache; 2006 Jan; 46(1):24-33. PubMed ID: 16412148 [TBL] [Abstract][Full Text] [Related]
13. Effects of anti-allergic drugs on substance P (SP) and vasoactive intestinal peptide (VIP) in nasal secretions. Shinoda M; Watanabe N; Suko T; Mogi G; Takeyama M Am J Rhinol; 1997; 11(3):237-41. PubMed ID: 9209598 [TBL] [Abstract][Full Text] [Related]
14. Radioimmunoassay for vasoactive intestinal polypeptide (VIP) in plasma before and during endoscopic examinations. Hossdorf T; Burger M; Burger M; Karoff C; van Husen N; Wagner H Hepatogastroenterology; 1982 Aug; 29(4):146-50. PubMed ID: 7129338 [TBL] [Abstract][Full Text] [Related]
15. [The relationship between skin test results and serum eosinophilic cationic protein, nasal eosinophilia, and total IgE values in patients with allergic rhinitis]. Pinar E; Bolat F; Oncel S; Köseoğlu M; Yüksel H; Calli C Kulak Burun Bogaz Ihtis Derg; 2005; 14(5-6):101-5. PubMed ID: 16340277 [TBL] [Abstract][Full Text] [Related]
16. [Observation of vasoactive intestinal polypeptide in patients with trigeminal neuralgia: a 16-cases report]. Zhao Y; Jiang X; Liu Y Hua Xi Kou Qiang Yi Xue Za Zhi; 2002 Feb; 20(1):33-4, 38. PubMed ID: 12593198 [TBL] [Abstract][Full Text] [Related]
17. Does pregnancy-associated plasma protein A have a role in allergic rhinitis? Güçlü E; Coskun A; Tokmak A; Duran S; Oztürk O; Akkan N; Egeli E Am J Rhinol; 2008; 22(3):219-22. PubMed ID: 18588751 [TBL] [Abstract][Full Text] [Related]
18. Up-regulation of peroxisome proliferator-activated receptor gamma in perennial allergic rhinitis. Kang HJ; Cinn YG; Hwang SJ; Won Chae S; Woo JS; Lee SH; Lee HM Arch Otolaryngol Head Neck Surg; 2006 Nov; 132(11):1196-200. PubMed ID: 17116814 [TBL] [Abstract][Full Text] [Related]
19. [The significance of vasoactive intestinal polypeptide (VIP) in diagnosis of sleep apnea syndrome]. Fischer J; Jackowski M Pneumologie; 1989 Nov; 43 Suppl 1():584-6. PubMed ID: 2608648 [TBL] [Abstract][Full Text] [Related]
20. Colonic vasoactive intestinal polypeptide (VIP) in ulcerative colitis--a radioimmunoassay and immunohistochemical study. Todorovic V; Janic B; Koko V; Micev M; Nikolic JA; Ratkovic M; Leposavic G; Jankovic T; Knezevic-Usaj S; Milicevic Z Hepatogastroenterology; 1996; 43(9):483-8. PubMed ID: 8799381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]